menu search

Iovance biotherapeutics to present at jefferies global healthcare conference

SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing ...

June 9, 2023, 11:01 am

Iovance biotherapeutics to present at jefferies global healthcare conference

SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing ...

June 9, 2023, 7:01 am

Ultragenyx to participate in the goldman sachs 44th annual global healthcare conference

NOVATO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developme...

June 7, 2023, 9:00 pm

Atara biotherapeutics to participate in the goldman sachs 44th annual global healthcare conference

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its <...

June 7, 2023, 4:01 pm

Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company f...

June 7, 2023, 11:30 am

Artelo biosciences selected for oral presentation to report positive research findings on art12.11 at the 33rd annual international cannabinoid research society symposium

ART12.11, a novel and Patented Cocrystal of Cannabidiol, Improves Bioavailability and Efficacy of CBD ...

June 7, 2023, 8:30 am

Aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023

SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company fo...

June 7, 2023, 7:30 am

Arbutus to present ab-729 and ab-836 data at easl congress 2023

WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveragin...

June 7, 2023, 6:01 am

Arbutus to present ab-729 and ab-836 data at easl congress 2023

WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...

June 7, 2023, 2:01 am

Reata pharmaceuticals announces participation in the goldman sachs 44th annual global healthcare conference

PLANO, Texas--(BUSINESS WIRE)--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a global...

June 6, 2023, 4:31 pm

Bruker's (brkr) latest workflows to aid applied markets

Bruker (BRKR) introduces novel EVOQ DART-TQ+ for chromatography-free mass spectrometry for applied mark...

June 6, 2023, 9:14 am

Ocular therapeutix™ to present 12-month top-line data from u.s.-based phase 1 clinical trial of otx-tki in wet age-related macular degeneration at the 2023 clinical trials at the summit annual meeting

BEDFORD, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, deve...

June 5, 2023, 4:01 pm

Ocugen, inc. announces business advisory board

MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...

June 5, 2023, 11:02 am

Elicio therapeutics reports inducement grant to new chief financial officer

BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotechnology company developing a pipeline of ...

June 2, 2023, 8:30 pm

Tracon pharmaceuticals to present at the jefferies healthcare conference

SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the d...

June 2, 2023, 12:00 pm

Inozyme pharma to present at the jefferies healthcare conference

BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing ...

June 2, 2023, 11:30 am

Aclaris therapeutics to participate in two june healthcare investor conferences

WAYNE, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on develo...

June 2, 2023, 11:00 am

Bayer (bayry) & cedilla to co-develop novel cancer therapies

Bayer (BAYRY) announces licensing agreement with Cedilla Therapeutics to jointly develop and commercialize the latter's selective protein complex inhi...

June 2, 2023, 8:23 am


Search within

Pages Search Results: